Publication | Closed Access

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Tumor DispositionMedicineMelanomaPharmacologyStealth Liposomal-cisplatin FormulationsDermatologySpi-077 B103Cancer TreatmentOncologyRadiation OncologyTumor BiologySkin Cancer